Ardalan E. Ahmad
Dr. Ernest W. Ramsey Manitoba Prostate Center
Winnipeg, MB, Canada
Winnipeg, MB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience.
Journal: BJU international
Published: May 20, 2026
Cases - Renal cell carcinoma with remote testicular metastases.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: March 21, 2025
2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: November 05, 2024
Radiographic predictors of muscle-invasive upper tract urothelial cancer A Canadian cohort.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: July 22, 2024
Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.
Journal: European urology
Published: February 14, 2023
Validating the total cancer location density metric for stratifying patients with low-risk localized prostate cancer at higher risk of grade group reclassification while on active surveillance.
Journal: Urologic oncology
Published: August 02, 2022
The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: December 23, 2021
Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?
Journal: BJU international
Published: September 14, 2020
Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis.
Journal: The Prostate
Published: September 06, 2020
Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?
Journal: Urologic oncology
Published: June 25, 2020
Last Updated: 09/26/2026